Home » PRECLINICAL COSTS REDUCED BY NEW HUMAN CELL CULTURE SYSTEM FROM NORTHERN GERMANY
PRECLINICAL COSTS REDUCED BY NEW HUMAN CELL CULTURE SYSTEM FROM NORTHERN GERMANY
The young biotech start up company Primacyt has developed a long-term human hepatocyte culture system that may be used as a biosensor for the analysis of drugs, food additives, and chemicals. The entrepreneur team has developed serum-free long-term culture techniques for hepatocytes. Currently, several other companies are validating this culture technique in a multi-center study.
Innovations Report
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May